• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

各种药物单独或联合对抗偶发分枝杆菌的活性。

Activity of various drugs alone or in combination against Mycobacterium fortuitum.

机构信息

Hospital General Universitario de Elche, Elche (Alicante), Spain.

出版信息

J Infect Chemother. 2010 Feb;16(1):64-7. doi: 10.1007/s10156-009-0008-1.

DOI:10.1007/s10156-009-0008-1
PMID:20063030
Abstract

Interest in Mycobacterium fortuitum has increased since it was recognized as an emergent pathogen. The objective of this study was to screen a large number of drug combinations in order to evaluate the activity of classical and new potentially useful antibiotics against M. fortuitum. Twenty M. fortuitum clinical isolates were studied with 51 combinations of two drugs and 47 combinations of three drugs belonging to different families: fluoroquinolones, linezolid, macrolides, rifamycins, aminoglycosides, and carbapenems. Activity was determined in Mueller Hinton broth by seeing whether the cultures were negative after 4 days of incubation with the combination of antibiotics. The most active drugs were moxifloxacin and gatifloxacin, which were active against 15 of the 20 strains studied, followed by amikacin (14 of the 20). The combinations of gatifloxacin with rifampicin or rifabutin, moxifloxacin with rifampicin or amikacin, and ciprofloxacin with amikacin were the most useful against M. fortuitum, as they showed activity in 18 of the 20 strains studied. Linezolid, imipenem, and ertapenem showed poor activity in this experimental model when they were used on their own. Larger studies, both in vitro and in vivo, should be done to confirm the true usefulness of the new fluoroquinolones, alone or in combination, in the treatment of M. fortuitum.

摘要

自从偶然分枝杆菌被认为是一种新出现的病原体以来,人们对它的兴趣日益增加。本研究的目的是筛选大量药物组合,以评估经典和新的潜在有用抗生素对偶然分枝杆菌的活性。研究了 20 株偶然分枝杆菌临床分离株,使用了 51 种二药组合和 47 种三药组合,这些药物组合属于不同的家族:氟喹诺酮类、利奈唑胺、大环内酯类、利福霉素类、氨基糖苷类和碳青霉烯类。在 Mueller Hinton 肉汤中通过观察在含有抗生素的混合物孵育 4 天后培养物是否为阴性来确定活性。最有效的药物是莫西沙星和加替沙星,它们对研究的 20 株菌株中的 15 株有效,其次是阿米卡星(20 株中的 14 株)。加替沙星与利福平或利福布汀、莫西沙星与利福平或阿米卡星、环丙沙星与阿米卡星的组合对偶然分枝杆菌最有效,因为它们对研究的 20 株菌株中的 18 株显示出活性。利奈唑胺、亚胺培南和厄他培南在这种实验模型中单独使用时活性较差。应进行更大规模的体外和体内研究,以确认新型氟喹诺酮类药物单独或联合使用在治疗偶然分枝杆菌方面的真正用途。

相似文献

1
Activity of various drugs alone or in combination against Mycobacterium fortuitum.各种药物单独或联合对抗偶发分枝杆菌的活性。
J Infect Chemother. 2010 Feb;16(1):64-7. doi: 10.1007/s10156-009-0008-1.
2
Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.分枝杆菌性角膜炎的局部抗菌治疗:手术预防和治疗的潜力
Clin Ther. 2004 Feb;26(2):191-6. doi: 10.1016/s0149-2918(04)90018-5.
3
Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.脓肿分枝杆菌、龟分枝杆菌和偶发分枝杆菌肉汤微量稀释法药敏试验结果的多中心可重复性。
J Clin Microbiol. 1999 Jun;37(6):1676-82. doi: 10.1128/JCM.37.6.1676-1682.1999.
4
In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria.新型氟喹诺酮类药物和利奈唑胺对非结核分枝杆菌的体外活性
Int J Antimicrob Agents. 2003 Jun;21(6):585-8. doi: 10.1016/s0924-8579(03)00048-7.
5
Susceptibility of and Isolates to 30 Antibiotics.30 种抗生素对 及 分离株的敏感性。
Biomed Res Int. 2018 Dec 30;2018:4902941. doi: 10.1155/2018/4902941. eCollection 2018.
6
[Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].[快速生长分枝杆菌的抗菌药敏性评估]
Mikrobiyol Bul. 2023 Apr;57(2):220-237. doi: 10.5578/mb.20239917.
7
In vitro bactericidal activity of antibiotic combinations against clinical isolates of Mycobacterium chelonae.抗生素组合对龟分枝杆菌临床分离株的体外杀菌活性。
J Chemother. 2008 Feb;20(1):43-7. doi: 10.1179/joc.2008.20.1.43.
8
Antibiotic resistance in and isolates from Malaysian patients.马来西亚患者分离出的[具体内容缺失]中的抗生素耐药性。
Int J Mycobacteriol. 2017 Oct-Dec;6(4):387-390. doi: 10.4103/ijmy.ijmy_152_17.
9
In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.伊朗非结核分枝杆菌的体外抗菌药敏性
Microb Drug Resist. 2016 Mar;22(2):172-8. doi: 10.1089/mdr.2015.0134. Epub 2015 Oct 15.
10
[Treatment of cutaneous infections due to Mycobacterium fortuitum: two cases].[偶然分枝杆菌所致皮肤感染的治疗:2例报告]
Ann Dermatol Venereol. 2008 Aug-Sep;135(8-9):591-5. doi: 10.1016/j.annder.2008.03.029. Epub 2008 Jul 26.

引用本文的文献

1
Emerging and re-emerging infectious disease in otorhinolaryngology.耳鼻咽喉科新发和再发传染病
Acta Otorhinolaryngol Ital. 2018 Apr;38(SUPPL. 1):S1-S106. doi: 10.14639/0392-100X-suppl.1-38-2018.